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Antipsychotic drugs of known antidiarrhoeal and anticalmodulin activity inhibited the cholera-toxin-catalysed ADP-ribosylation of proteins of 
&f, 37000,40000 and 45000 (thought o be regulatory components of the adenylate cyclase complex) that was previously shown to occur in plasma 
membranes from rabbit intestinal epitheliai cells [(I989) B&him. Biophys. Acta 1014, 289297j. There was no obvious correlation between the 
different activities of the drugs. The drugs also inhibited adenylate cyclase activity, but in this case the inhibition correlated well with the known 
IC,, values of the drugs for anticalmodulin activity and with their antidiarrhoeal activities. 
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1. INTRODUCTION 
Cholera toxin triggers the hypersecretion of fluids in- 
to the lumen of the small intestine, leading to the char- 
acteristic watery diarrhoea of cholera. This massive 
water loss is almost certainly caused by the permanent 
activation of the adenylate cyclase catalytic subunit, 
The Al peptide of the toxin transfers the ADP-ribose 
moiety of NAD+ to the CY subunit of G, (the regulatory, 
stimulatory subunit of adenylate cyclase). G, interacts 
with the catalytic subunit of adenylate cyclase, resulting 
in the permanent activation of the enzyme and, hence, 
in an increase in the production of cyclic AMP in the 
cell [ 1,2]. This increase in the cyclic AMP content is 
presumably responsible, through protein kinases [3], 
for the stimulation of chloride secretion and the inhibi- 
tion of sodium chloride absorption that give rise to the 
loss of water. 
both high affinity and specificity, and so this has been 
proposed as a mechanism of their action [ 12-151. In 
fact, a correlation between the high affinity for 
calmodulin and the antisecretory activity of many 
drugs has been shown [16-191. 
The concentration of calcium is also thought to be in- 
volved in the control of ion secretion [4-61, and the 
calcium-binding protein calmodulin has been suggested 
to be important in mediating these events [7,8]. The 
binding of calcium-activated calmodulin activates a 
number of calcium-dependent enzymes including 
adenylate cyclase [9] and protein kinases [lO,l I]. A 
class of antipsychotic drugs known as the phenothi- 
azines has been found to inhibit the cholera-toxin- 
induced diarrhoea by mecha~sms which are not as yet 
fully understood. However, these phenothiazines bind 
to calmodulin in a calcium-dependent manner with 
In this paper, we have investigated the effects of six 
drugs, with differing anticalmodulin and antidiarrhoeal 
activities, on the activation of adenylate cyclase and the 
ADP-ribosylation of membrane proteins. The antical- 
modulin activity of a drug is its ability to inhibit the 
c~modulin-induced activation of phosphodiesterase in
vitro 1151. The ICSO values for this inhibition of 17, 28, 
40, 110 and 340pM for trifluoperazine, trifluprom- 
azine, chlorpromazine, promazine and promethazine 
(all phenothiazines), respectively, and of 1OOpM for 
~itriptyline (a di~nz~epine) [ 15,19,20], correlate 
well with their abilities to inhibit the diarrhoea induced 
by cholera toxin and other agents, such as prosta- 
glandins and vasoactive intestinal peptide [7,18,19, 
21,221. Trifluoperazine, chlorpromazine and triflupro- 
mazine have a greater antidiarrhoeal activity than 
amitriptyline, promazine and prometh~ine. 
2. MATERIALS AND METHODS 
2.1. Materials 
[~Y-~‘P]ATP was bought from Amersham Internatio~i and 
[adenylate-32P]NAD+ from New England Nuclear. Cholera toxin and 
the six drugs were from Sigma Chemical Co. 
2.2. Preparation of membranes 
CorreSpondence (present) address: D. Longbottom, MRC Human 
Genetics Unit, Western General Hospital, Crewe Road, Edinburgh 
EH4 2XU, UK 
A mixture of brush border and basal-lateral membranes (mixed 
plasma membranes) was prepared from one male white New Zealand 
rabbit as described previously by Longbottom and van Heyningen 
f231. 
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2.3. Preparation of drug solutions 
The drugs were freshly prepared for each experiment, as a 5 mM 
stock solution in double-distilled water, because they are very light- 
sensitive and oxidize on prolonged exposure to air, acquiring a blue 
or pink colour. 
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2.4. ADP-ribosylation assay 
Membrane proteins (50 cg) were ADP-ribosylated with 20 pg/ml 
activated cholera toxin and 5 pM [adenylate-32P]NAD+ (25-35 Ci/ 
mmol) as in Longbottom and van Heyningen [23]. For investigating 
drug effects, solutions of freshly prepared drugs were added to the 
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Fig. 1. Effect of antidiarrhoeal drugs on the ADP-ribosylation of mixed plasma membrane proteins: 45 kDa (0), 40 kDa (m) and 37 kDa (A). 
A value of 1 for the incorporation of [32P]ADP-ribose into proteins corresponds to an integrated value of 30000 arbitrary density units, obtained 
from the densitometric analysis of the autoradiographs. 
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ADP-ribosylation assay reaction mixture giving final concentrations 
of 0.1, 0.2, 0.4, 0.7 and 1.0 mM. Membranes were solubilized and 
analyzed by polyacrylamide gel electrophoresis n SDS on a 10% gel 
as in [23]. The incorporation of 32P into membrane proteins was 
estimated by densitometric analysis after autoradiography of dried 
gels. The absorbance signals corresponding to radiolabelled proteins 
were converted to arbitrary units from the printout of integrated 
values. 
2.5. Adenylate cyclase assay 
Adenylate cyclase was assayed by determining the amount of cyclic 
[“PIAMP produced from [u-~~P]ATP [23]. For investigating drug 
effects, the freshly prepared drugs were added to the adenylate 
cyclase assay reaction mixture in 1231 to give final concentrations of 
0.1, 0.5, 1.0, 1.5, 2.0and 3.0mM. 
3. RESULTS AND DISCUSSION 
The action of the toxin is complicated, but is thought 
to be ultimately due to its ADP-ribosylation of the 
regulatory proteins of the adenylate cyclase complex, 
and the consequent increase in the concentration of 
cyclic AMP in the intestinal cells. An involvement of 
prostaglandins has also been suggested [24]. Our 
previous work using rabbit intestinal epithelial cells 
showed that the toxin causes ADP-ribosylation of three 
proteins of 45,40 and 37 kDa in the brush border mem- 
brane [23]. The identities of these proteins have not 
been determined, although the results indicated that the 
45 and 40 kDa proteins were probably two forms of 
G SCY. 
The effects of the drugs on the cholera-toxin-induced 
ADP-ribosylation of the 45, 40 and 37 kDa proteins in 
the mixed plasma (brush border and basal-lateral) 
membrane fraction are shown in Fig. 1. Purified brush 
border and basal-lateral membranes were also in- 
vestigated but the results were similar to those for the 
mixed fraction and so are not shown in this paper: the 
patterns of inhibition were the same, but the values for 
the incorporation of [“P]ADP-ribose into the proteins 
in the absence of drug were different because of cross- 
contamination of the membrane preparations, as 
discussed in [23]. No concentrations of trifluoperazine 
above 0.7 mM are shown in Fig. IC because the drug 
was at least partly insoluble above this concentration. 
However, since inhibition had reached a maximum by 
about 0.5 mM, this has not affected the result in any 
way. 
Although there is so much inhibition of ADP- 
ribosylation, there does not appear to be any correla- 
tion of this inhibition with the known antidiarrhoeal 
and anticalmodulin activities of the drugs. An excep- 
tion to this is trifluoperazine, which has both the 
greatest anticalmodulin and antisecretory activity of all 
the drugs, as well as the greatest inhibitory effect on the 
ADP-ribosylation of the 40 kDa protein in particular. 
The fact that they do all cause a clear inhibition of 
ADP-ribosylation does suggest some unknown mecha- 
nism that might involve both calmodulin and ADP- 
ribosyltransferase activities. Calmodulin has been 
found to have an action in so many different systems 
that it must be possible that it is also involved here. 
Although the inhibition of ADP-ribosylation by the 
phenothiazines was unexpected, there was good reason 
to believe that they would inhibit adenylate cyclase ac- 
tivity, since the drugs are known to bind calmodulin 
[ 151 and calmodulin is known to be involved in the ac- 
tivation of adenylate cyclase [9]. Fig. 2 shows that such 
inhibition was observed, and illustrates the effects of 
the drugs on adenylate cyclase activity in the mixed 
plasma membrane fraction. Again purified brush 
border and basal-lateral membranes were investigated, 
but gave the same pattern of inhibition as the mixed 
membrane fraction and so are not shown. Trifluo- 
perazine appeared to come out of solution at concen- 
trations greater than about 1.5 mM (higher than in the 
ADP-ribosylation experiments probably because of a 
difference in the ionic strengths), but, as before, inhibi- 
tion by this drug had reached a maximum at about 
1.0 mM (Fig. 2). 
The order of the drugs for producing the greatest in- 
hibition of cyclase activity (trifluoperazine > chlor- 
promazine, triflupromazine > amitriptyline > 
promazine > promethazine, see Fig. 2) correlates well 
with the known I& values for the inhibition of 
calmodulin activity [15], as well as with the known an- 
tidiarrhoeal activities of the drugs [19,20]; trifluope- 
razine, chlorpromazine and triflupromazine have 
greater antidiarrhoeal activities than the other drugs. 
Therefore, the results of this study show that there is 
a relationship between the binding of the drugs to 
calmoduhn, with their effect on the movement of ions 
4o I 
0 
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Fig. 2. Effect of antidiarrhoeal drugs on the activation of adenylate 
cyclase by cholera toxin. The drugs used were chlorpromazine (A), 
amitriptyline ( q ), trifluoperazine (m), promethazine (o), 
triflupromazine (+) and promazine (A). 
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across the brush border membrane and with their effect 
on adenylate cyclase activity. Unfortunately, no similar 
relationship could be found when investigating the ef- 
fects of the drugs on ADP-ribosylation, although the 
drugs do cause inhibition. 
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